A rapid investigation in North East England uncovered 25 cases of iatrogenic botulism linked to cosmetic injections using unlicensed, highly potent botulinum products. The study exposes critical safety failures in practitioner conduct and highlights urgent regulatory gaps in the booming cosmetic injectables industry.